• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nfil3-Zeb2-Id2 通路在 cDC1 发育过程中诱导 Irf8 增强子切换。

An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.

机构信息

Department of Pathology and Immunology, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.

Howard Hughes Medical Institute, Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.

出版信息

Nat Immunol. 2019 Sep;20(9):1174-1185. doi: 10.1038/s41590-019-0449-3. Epub 2019 Aug 12.

DOI:10.1038/s41590-019-0449-3
PMID:31406377
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6707889/
Abstract

Classical type 1 dendritic cells (cDC1s) are required for antiviral and antitumor immunity, which necessitates an understanding of their development. Development of the cDC1 progenitor requires an E-protein-dependent enhancer located 41 kilobases downstream of the transcription start site of the transcription factor Irf8 (+41-kb Irf8 enhancer), but its maturation instead requires the Batf3-dependent +32-kb Irf8 enhancer. To understand this switch, we performed single-cell RNA sequencing of the common dendritic cell progenitor (CDP) and identified a cluster of cells that expressed transcription factors that influence cDC1 development, such as Nfil3, Id2 and Zeb2. Genetic epistasis among these factors revealed that Nfil3 expression is required for the transition from Zeb2 and Id2 CDPs to Zeb2 and Id2 CDPs, which represent the earliest committed cDC1 progenitors. This genetic circuit blocks E-protein activity to exclude plasmacytoid dendritic cell potential and explains the switch in Irf8 enhancer usage during cDC1 development.

摘要

经典型 1 树突状细胞 (cDC1) 对于抗病毒和抗肿瘤免疫是必需的,这就需要了解它们的发育过程。cDC1 祖细胞的发育需要一个依赖 E 蛋白的增强子,该增强子位于转录因子 Irf8 的转录起始位点下游 41kb(+41-kb Irf8 增强子),但其成熟则需要依赖 Batf3 的+32-kb Irf8 增强子。为了理解这种转变,我们对共同树突状细胞祖细胞 (CDP) 进行了单细胞 RNA 测序,鉴定出一群表达影响 cDC1 发育的转录因子的细胞,如 Nfil3、Id2 和 Zeb2。这些因子之间的遗传上位性表明,Nfil3 的表达对于从 Zeb2 和 Id2 CDP 向 Zeb2 和 Id2 CDP 的转变是必需的,后者代表最早的定向 cDC1 祖细胞。这种遗传回路阻止了 E 蛋白的活性,排除了浆细胞样树突状细胞的潜能,并解释了 cDC1 发育过程中 Irf8 增强子使用的转变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/d083465c5f35/nihms-1532199-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/fe1395d0a93b/nihms-1532199-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/c7b2680952b1/nihms-1532199-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/07e6df7d9834/nihms-1532199-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/c286b3c85343/nihms-1532199-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/8c0df639410f/nihms-1532199-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/a5f75f11033d/nihms-1532199-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/d083465c5f35/nihms-1532199-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/fe1395d0a93b/nihms-1532199-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/c7b2680952b1/nihms-1532199-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/07e6df7d9834/nihms-1532199-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/c286b3c85343/nihms-1532199-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/8c0df639410f/nihms-1532199-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/a5f75f11033d/nihms-1532199-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac70/6707889/d083465c5f35/nihms-1532199-f0007.jpg

相似文献

1
An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.Nfil3-Zeb2-Id2 通路在 cDC1 发育过程中诱导 Irf8 增强子切换。
Nat Immunol. 2019 Sep;20(9):1174-1185. doi: 10.1038/s41590-019-0449-3. Epub 2019 Aug 12.
2
Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.通过 Zeb2 增强子内的三重突变消融 cDC2 的发育。
Nature. 2022 Jul;607(7917):142-148. doi: 10.1038/s41586-022-04866-z. Epub 2022 Jun 22.
3
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.IRF8 增强子的隐匿激活控制 cDC1 命运特化。
Nat Immunol. 2019 Sep;20(9):1161-1173. doi: 10.1038/s41590-019-0450-x. Epub 2019 Aug 12.
4
Anatomy of a superenhancer.超级增强子的结构
Adv Immunol. 2024;163:51-96. doi: 10.1016/bs.ai.2024.08.001. Epub 2024 Aug 31.
5
CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3.CD8α+ DCs 可在缺乏转录因子 Id2、Nfil3 和 Batf3 的情况下诱导产生。
Blood. 2013 Feb 28;121(9):1574-83. doi: 10.1182/blood-2012-07-445650. Epub 2013 Jan 7.
6
IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.IRF8 和 BATF3 相互作用增强了 cDC1 特异性 Pfkfb3 基因的表达。
Cell Immunol. 2022 Jan;371:104468. doi: 10.1016/j.cellimm.2021.104468. Epub 2021 Dec 10.
7
Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8α+ dendritic cell development.Batf3 和 Id2 对 Irf8 指导的经典 CD8α+树突状细胞发育具有协同作用。
J Immunol. 2013 Dec 15;191(12):5993-6001. doi: 10.4049/jimmunol.1203541. Epub 2013 Nov 13.
8
Optimization of the Irf8 +32-kb enhancer disrupts dendritic cell lineage segregation.优化 Irf8 +32-kb 增强子会破坏树突状细胞谱系分离。
Nat Immunol. 2024 Nov;25(11):2043-2056. doi: 10.1038/s41590-024-01976-w. Epub 2024 Oct 7.
9
C/EBPα activates expression in myeloid progenitors at the +56-kb enhancer to initiate cDC1 development.C/EBPα 在 +56-kb 增强子处激活髓系祖细胞中的表达,以启动 cDC1 发育。
Sci Immunol. 2025 May 16;10(107):eadt5899. doi: 10.1126/sciimmunol.adt5899.
10
The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2.转录因子Zeb2通过抑制Id2来调节传统树突状细胞和浆细胞样树突状细胞的发育。
J Exp Med. 2016 May 30;213(6):897-911. doi: 10.1084/jem.20151715. Epub 2016 May 16.

引用本文的文献

1
Piezo1-mediated mechanotransduction regulates the translational activity, function and lung pathogenicity of group 2 innate lymphoid cells.Piezo1介导的机械转导调节2型天然淋巴细胞的翻译活性、功能及肺部致病性。
Signal Transduct Target Ther. 2025 Aug 21;10(1):269. doi: 10.1038/s41392-025-02350-4.
2
The Biology of Dendritic Cells: In Health and Disease.树突状细胞生物学:健康与疾病状态下的情况
Adv Exp Med Biol. 2025;1476:1-30. doi: 10.1007/978-3-031-85340-1_1.
3
Diverse developmental pathways of lymphoid conventional dendritic cells with distinct tissue distribution and function.

本文引用的文献

1
Key regulators control distinct transcriptional programmes in blood progenitor and mast cells.关键调节因子控制造血祖细胞和肥大细胞中不同的转录程序。
EMBO J. 2014 Jun 2;33(11):1212-26. doi: 10.1002/embj.201386825. Epub 2014 Apr 23.
具有不同组织分布和功能的淋巴样常规树突状细胞的多种发育途径。
Sci Adv. 2025 Jun 6;11(23):eadt4909. doi: 10.1126/sciadv.adt4909.
4
WNK1 mediates M-CSF-induced macropinocytosis to enforce macrophage lineage fidelity.WNK1介导集落刺激因子-1诱导的巨胞饮作用以强化巨噬细胞谱系保真度。
Nat Commun. 2025 May 28;16(1):4945. doi: 10.1038/s41467-025-59901-0.
5
Intrathymic Regulation of Dendritic Cell Subsets and Their Contributions to Central Tolerance.胸腺内树突状细胞亚群的调节及其对中枢耐受的贡献。
Immunol Rev. 2025 Jul;332(1):e70039. doi: 10.1111/imr.70039.
6
Transcriptional and chromatin accessibility landscapes of hematopoiesis in a mouse model of breast cancer.乳腺癌小鼠模型中造血作用的转录和染色质可及性图谱
J Immunol. 2025 Jun 1;214(6):1384-1397. doi: 10.1093/jimmun/vkaf026.
7
Cross-priming in cancer immunology and immunotherapy.癌症免疫学与免疫治疗中的交叉呈递
Nat Rev Cancer. 2025 Apr;25(4):249-273. doi: 10.1038/s41568-024-00785-5. Epub 2025 Jan 29.
8
Optimization of the Irf8 +32-kb enhancer disrupts dendritic cell lineage segregation.优化 Irf8 +32-kb 增强子会破坏树突状细胞谱系分离。
Nat Immunol. 2024 Nov;25(11):2043-2056. doi: 10.1038/s41590-024-01976-w. Epub 2024 Oct 7.
9
Microbiota-derived butyrate inhibits cDC development via HDAC inhibition, diminishing their ability to prime T cells.微生物群衍生的丁酸通过抑制组蛋白去乙酰化酶来抑制树突状细胞的发育,从而削弱它们激活T细胞的能力。
Mucosal Immunol. 2024 Dec;17(6):1199-1211. doi: 10.1016/j.mucimm.2024.08.003. Epub 2024 Aug 13.
10
Transcriptional programming mediated by the histone demethylase KDM5C regulates dendritic cell population heterogeneity and function.组蛋白去甲基酶 KDM5C 介导的转录编程调节树突状细胞群体异质性和功能。
Cell Rep. 2024 Aug 27;43(8):114506. doi: 10.1016/j.celrep.2024.114506. Epub 2024 Jul 24.